Literature DB >> 6949617

Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.

T Goto, M Nishikori, Z Arlin, T Gee, S Kempin, J Burchenal, A Strife, D Wisniewski, C Lambek, C Little, S Jhanwar, R Chaganti, B Clarkson.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6949617

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  An overview of bone marrow transplantation for chronic myeloid leukemia.

Authors:  M J Barnett; A C Eaves; G L Phillips
Journal:  CMAJ       Date:  1990-08-01       Impact factor: 8.262

2.  Bone marrow tissue and proliferation markers: results and general problems.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

3.  Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.

Authors:  C Udomsakdi; C J Eaves; B Swolin; D S Reid; M J Barnett; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 4.  Benign hematopoietic progenitors in chronic myeloid leukemia: current status and future prospects.

Authors:  F Cervantes; C Rozman
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

Review 5.  Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status.

Authors:  G Marcoullis; J Mehta; J Treleaven
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

6.  Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders.

Authors:  A Matolcsy; R Nádor; E Wéber; T Kónya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.

Authors:  C J Eaves; J D Cashman; S D Wolpe; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder.

Authors:  A G Turhan; R K Humphries; J D Cashman; D A Cuthbert; C J Eaves; A C Eaves
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

9.  Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone.

Authors:  Z A Arlin; E Berman; S Jhanwar; R Gams; I Schoch; G Dukart
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.

Authors:  I Sloma; S Imren; P A Beer; Y Zhao; V Lecault; D Leung; K Raghuram; C Brimacombe; K Lambie; J Piret; C Hansen; R K Humphries; C J Eaves
Journal:  Leukemia       Date:  2012-07-16       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.